First Time Loading...

Bellerophon Therapeutics Inc
NASDAQ:BLPH

Watchlist Manager
Bellerophon Therapeutics Inc Logo
Bellerophon Therapeutics Inc
NASDAQ:BLPH
Watchlist
Price: 0.0625 USD 21.83% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one BLPH stock under the Base Case scenario is 19.1934 USD. Compared to the current market price of 0.0625 USD, Bellerophon Therapeutics Inc is Undervalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLPH Relative Value
Base Case
19.1934 USD
Undervaluation 100%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.1
P/S
P/S
Price to Sales
0.1
vs History
15
vs Industry
92
Median 3Y
0
Median 5Y
0
Industry
2.4
Forward
0.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-1.6
Industry
23.2
Forward
-0.1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.7
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.7
Industry
23.5
More Details
0.1
P/B
P/B
Price to Book Value
0.1
vs History
92
vs Industry
83
Median 3Y
1.3
Median 5Y
1.5
Industry
2.2
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.5
Forward
-1.7
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.2
More Details
0.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0.7
vs History
4
vs Industry
54
Median 3Y
0
Median 5Y
-0.4
Industry
12.5
More Details
0.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0.7
vs History
4
vs Industry
51
Median 3Y
0
Median 5Y
-0.4
Industry
17.2
Forward
0.8
More Details
0.9
EV/OCF
EV/OCF
Enterprise Value to OCF
0.9
vs History
4
vs Industry
54
Median 3Y
0.1
Median 5Y
-0.5
Industry
15.1
More Details
0.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0.9
vs History
4
vs Industry
44
Median 3Y
0.1
Median 5Y
-0.5
Industry
19.7
More Details
8.1
EV/IC
EV/IC
Enterprise Value to IC
8.1
vs History
44
vs Industry
10
Median 3Y
4.3
Median 5Y
8.1
Industry
2
More Details

Multiples Across Competitors

BLPH Competitors Multiples
Bellerophon Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bellerophon Therapeutics Inc
NASDAQ:BLPH
764.5k USD 0.1 -0.1 0.7 0.7
US
Abbott Laboratories
NYSE:ABT
183.7B USD 4.6 32.6 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
134B USD 18.3 67.4 55.3 69.3
US
Stryker Corp
NYSE:SYK
124.3B USD 5.9 37 24 29.6
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.3 25.6 13.6 19.3
US
Boston Scientific Corp
NYSE:BSX
105.6B USD 7.2 59.8 30.5 45
US
Becton Dickinson and Co
NYSE:BDX
69.4B USD 3.6 57 19 40.2
DE
Siemens Healthineers AG
XETRA:SHL
57.6B EUR 2.6 38 18.3 30.8
US
Edwards Lifesciences Corp
NYSE:EW
51.2B USD 8.3 36.2 26.3 28.5
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3
US
Dexcom Inc
NASDAQ:DXCM
50.2B USD 13.2 78.5 58.6 76.4

See Also

Summary
BLPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
BLPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BLPH stock valuation using valuation multiples.
Wall Street Estimates
BLPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BLPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.